XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.1
Acquisition of Flame Biosciences - Fair value assigned to each component of the purchase consideration (Details) - Flame
$ in Thousands
Jan. 17, 2023
USD ($)
shares
Acquisition of Flame Biosciences  
Equivalent common shares 15,648,531
Fair Value | $ $ 1,393
Direct and incremental costs of the asset acquisition | $ 1,393
Total | $ $ 79,016
Common stock  
Acquisition of Flame Biosciences  
Number of shares 1,972,901
Equivalent common shares 1,972,901
Fair Value | $ $ 9,805
Common stock | Warrant Liability  
Acquisition of Flame Biosciences  
Number of shares 6,530
Equivalent common shares 6,530
Fair Value | $ $ 13
Series X Preferred Shares  
Acquisition of Flame Biosciences  
Number of shares 136,248
Equivalent common shares 13,624,800
Fair Value | $ $ 67,715
Series X Preferred Shares | Warrant Liability  
Acquisition of Flame Biosciences  
Number of shares 443
Equivalent common shares 44,300
Fair Value | $ $ 90